Tim Ocain - Net Worth and Insider Trading
Tim Ocain Net Worth
The estimated net worth of Tim Ocain is at least $65,314 dollars as of 2024-11-13. Tim Ocain is the Senior Vice President of Enanta Pharmaceuticals Inc and owns about 6,127 shares of Enanta Pharmaceuticals Inc (ENTA) stock worth over $65,314. Details can be seen in Tim Ocain's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tim Ocain has not made any transactions after 2018-10-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Tim Ocain
Tim Ocain Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tim Ocain owns 1 companies in total, including Enanta Pharmaceuticals Inc (ENTA) .
Click here to see the complete history of Tim Ocain’s form 4 insider trades.
Insider Ownership Summary of Tim Ocain
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc | 2018-10-01 | Senior Vice President |
Tim Ocain Latest Holdings Summary
Tim Ocain currently owns a total of 1 stock. Tim Ocain owns 6,127 shares of Enanta Pharmaceuticals Inc (ENTA) as of October 1, 2018, with a value of $65,314.
Latest Holdings of Tim Ocain
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc | 2018-10-01 | 6,127 | 10.66 | 65,314 |
Holding Weightings of Tim Ocain
Tim Ocain Form 4 Trading Tracker
According to the SEC Form 4 filings, Tim Ocain has made a total of 0 transactions in Enanta Pharmaceuticals Inc (ENTA) over the past 5 years. The most-recent trade in Enanta Pharmaceuticals Inc is the sale of 25,000 shares on October 1, 2018, which brought Tim Ocain around $2 Million.
Insider Trading History of Tim Ocain
- 1
Tim Ocain Trading Performance
Tim Ocain Ownership Network
Ownership Network List of Tim Ocain
Ownership Network Relation of Tim Ocain
Tim Ocain Owned Company Details
What does Enanta Pharmaceuticals Inc do?
Who are the key executives at Enanta Pharmaceuticals Inc?
Tim Ocain is the Senior Vice President of Enanta Pharmaceuticals Inc. Other key executives at Enanta Pharmaceuticals Inc include Chief Medical Officer Scott T. Rottinghaus , Sr. VP & New Product Dev. Tara Lynn Kieffer , and Sr. VP & Business Dev. Brendan Luu .
Enanta Pharmaceuticals Inc (ENTA) Insider Trades Summary
Over the past 18 months, Tim Ocain made no insider transaction in Enanta Pharmaceuticals Inc (ENTA). Other recent insider transactions involving Enanta Pharmaceuticals Inc (ENTA) include a net sale of 12,479 shares made by Scott T. Rottinghaus , a net sale of 9,391 shares made by Tara Lynn Kieffer , and a net sale of 15,295 shares made by Terry Vance .
In summary, during the past 3 months, insiders sold 0 shares of Enanta Pharmaceuticals Inc (ENTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 53,756 shares of Enanta Pharmaceuticals Inc (ENTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 53,756 shares.
Enanta Pharmaceuticals Inc (ENTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enanta Pharmaceuticals Inc Insider Transactions
Tim Ocain Mailing Address
Above is the net worth, insider trading, and ownership report for Tim Ocain. You might contact Tim Ocain via mailing address: C/o Enanta Pharmaceuticals, Inc., 500 Arsenal Street, Watertown Ma 02472.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
